Search for a rare disease
Other search option(s)
AGel amyloidosis
Disease definition
A rare, systemic amyloidosis characterized by a triad of ophthalmologic, neurologic and dermatologic findings due to the deposition of gelsolin amyloid fibrils in these tissues. Clinical manifestations include corneal lattice dystrophy, cranial neuropathy, especially affecting the facial nerve, bulbar signs, cutis laxa, increased skin fragility, and less commonly peripheral neuropathy and renal failure.
ORPHA:85448
Classification level: Disorder- Synonym(s):
- Familial amyloid polyneuropathy type IV
- Familial amyloidosis, Finnish type
- Gelsolin amyloidosis
- Hereditary amyloidosis, Finnish type
- Prevalence: Unknown
- Inheritance: Autosomal dominant
- Age of onset: Adult
- ICD-10: E85.1
- ICD-11: 5D00.2Y
- OMIM: 105120
- UMLS: C0936273
- MeSH: -
- GARD: 2339
- MedDRA: -
A summary on this disease is available in Español (2018) Français (2018) Italiano (2018) Nederlands (2018)
Detailed information
General public
- Article for general public
- English (2012) - Socialstyrelsen
- Français (2014) - SNFMI
- Svenska (2015) - Socialstyrelsen
Guidelines
- Clinical practice guidelines
- Français (2017) - PNDS
Disease review articles
- Review article
- English (2009) - Orphanet J Rare Dis


Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.